R. Felberbaum

ORCID: 0000-0001-9727-0119 · 26 papers in corpus
article 2025
·doi:10.1007/s10304-025-00627-z
article 2025
·doi:10.1007/s00129-025-05392-5
article 2024
·doi:10.1007/s00129-024-05203-3
book-chapter 2024
·doi:10.1016/b978-3-437-23044-8.00003-3
article 2024
·doi:10.1007/s10304-024-00567-0
article 2024
·doi:10.1007/s00129-024-05280-4
article 2023
·doi:10.1007/s10304-023-00524-3
article 2023
·doi:10.1007/s10304-023-00522-5
article 2023
·doi:10.1007/s10304-023-00502-9
article 2022
·doi:10.1055/s-0042-1749063

Einleitung Verschiedene Scoresysteme zur klinischen Einteilung der Endometriose existieren seit mehreren Jahrzehnten. Es hat bisher jedoch kein System ermöglicht eine solche umfassende Beschreibung der Krankheit zu gewährleisten wie es in a…

article 2022
·doi:10.1007/s00129-022-04951-4
article 2020
·doi:10.1007/s00129-020-04633-z
article 2020
·doi:10.1007/s10304-020-00329-8
article 2019
·doi:10.1007/s10304-019-0248-9
book-chapter 2009
·doi:10.1016/b978-343723041-7.10003-8
review 2005
Archives of gynecology and obstetrics ·doi:10.1007/s00404-005-0021-2

Suppression of sex steroid production based on desensitisation and down-regulation of pituitary gonadotropin-releasing hormone (GnRH)-receptors by agonistic GnRH-analogues resulting in the blockage of gonadotropin release from the anterior …

book 2004
·doi:10.1007/978-3-7091-0574-0
article 2004
·doi:10.1016/j.fertnstert.2004.07.185
article 2003
·doi:10.1007/s10304-003-0032-7
article 2002
·doi:10.1007/s00129-002-1176-6
article 2002
Reproductive BioMedicine Online ·doi:10.1016/s1472-6483(10)61590-8

Endometriosis is an oestrogen-dependent disease that is treatable by oestrogen withdrawal, a therapy that has been effectively provided by the use of a gonadotrophin-releasing hormone (GnRH) agonist. Complete oestrogen withdrawal results in…

review 2002
Reproductive BioMedicine Online ·doi:10.1016/s1472-6483(11)60220-4

While GnRH agonists have become well-established tools for preoperative treatment of uterine fibroids or postoperative treatment in endometriosis for 3-6 months, GnRH antagonists seem to offer important advantages due to their specific phar…

article 1999
·doi:10.1007/s004040050256

A patient is reported, who suffered from ovarian abscess after ovarian puncture of a functional ovarian cyst. The cyst has developed after administration of a GnRH agonist depot preparation in the preceeding luteal phase. She was planned to…

article 1997
·doi:10.1093/humrep/12.suppl_2.25
article 1996
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1022267

Macrophage-derived substances such as cytokines and growth promoting factors are known to be present in the peritoneal fluid of women with endometriosis. Active endometriosis of the peritoneum is characterised by hypervascularization and ne…